Partek Incorporated | Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin..

2010 | Citations | Cancer Research

Falini, B., Macijewski, K., Weiss, T., Bacher, U., Schnittger, S., Kern, W., Kolhmann, A., Klein, H-U., Vignetti, M., Piciocchi, A., Fazi, P., Martelli, M.P., Vitale, A., Pileri, S., Miesner, M., Santucci, A., Haferlach, C., Mandelli, F., & Haferlach, T. Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1). Blood, 2010; 115(18):3776-3786. doi:10.1182/blood-2009-08-240457.